retatrutide phase 2 type 2 diabetes trial 🚨Breaking: Retatrutide's first 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending retatrutide phase 2 trial type

1 Like AgentSmith February 10, 2024, 2:43pm #14 I came across this thread searching for GLP-1 impacts on mTOR (a curiosity), and can describe my experience

What Is Carnipure

Broadway st Chicago, IL 60613 773-360-8501......#b12 #b12injections #b12chicago olaser #chicagobotox #chicagomedicalspa #vesperchi #vesperaesthetics #vespermedspa #laser #skincare #chicagomedspa #chicagomedicalspa #vesperchi #chicago #chicagobotox #chicagofiller #boystown #lgbtqprovider #nursejuancarlos #lakeviewchicago #northhalstedbusinessalliance #46thwardchicago | JuanCarlos Delgado RN LE

The on-target indel efficiency at the Alb locus was 20.2% in the Donor+Cas9-treated group (Supplementary Fig